Literature DB >> 24222334

Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Zarko Alfirevic1, Tamara Stampalija, Gillian M L Gyte.   

Abstract

BACKGROUND: Abnormal blood flow patterns in fetal circulation detected by Doppler ultrasound may indicate poor fetal prognosis. It is also possible false positive Doppler ultrasound findings could encourage inappropriate early delivery.
OBJECTIVES: The objective of this review was to assess the effects of Doppler ultrasound used to assess fetal well-being in high-risk pregnancies on obstetric care and fetal outcomes. SEARCH
METHODS: We updated the search of the Cochrane Pregnancy and Childbirth Group's Trials Register on 30 September 2013. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials of Doppler ultrasound for the investigation of umbilical and fetal vessels waveforms in high-risk pregnancies compared with no Doppler ultrasound. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. Data entry was checked. MAIN
RESULTS: Eighteen completed studies involving just over 10,000 women were included. The trials were generally of unclear quality with some evidence of possible publication bias. The use of Doppler ultrasound in high-risk pregnancy was associated with a reduction in perinatal deaths (risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52 to 0.98, 16 studies, 10,225 babies, 1.2% versus 1.7 %, number needed to treat (NNT) = 203; 95% CI 103 to 4352). There were also fewer inductions of labour (average RR 0.89, 95% CI 0.80 to 0.99, 10 studies, 5633 women, random-effects) and fewer caesarean sections (RR 0.90, 95% CI 0.84 to 0.97, 14 studies, 7918 women). No difference was found in operative vaginal births (RR 0.95, 95% CI 0.80 to 1.14, four studies, 2813 women), nor in Apgar scores less than seven at five minutes (RR 0.92, 95% CI 0.69 to 1.24, seven studies, 6321 babies). AUTHORS'
CONCLUSIONS: Current evidence suggests that the use of Doppler ultrasound in high-risk pregnancies reduced the risk of perinatal deaths and resulted in less obstetric interventions. The quality of the current evidence was not of high quality, therefore, the results should be interpreted with some caution. Studies of high quality with follow-up studies on neurological development are needed.

Entities:  

Mesh:

Year:  2013        PMID: 24222334      PMCID: PMC6464948          DOI: 10.1002/14651858.CD007529.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  64 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

Review 2.  Doppler ultrasound for fetal assessment in high risk pregnancies.

Authors:  J P Neilson; Z Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

4.  The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens.

Authors:  A A Baschat; U Gembruch; C R Harman
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

5.  Monitoring of fetuses with intrauterine growth restriction: a longitudinal study.

Authors:  K Hecher; C M Bilardo; R H Stigter; Y Ville; B J Hackelöer; H J Kok; M V Senat; G H Visser
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

6.  A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics.

Authors:  H B Westergaard; J Langhoff-Roos; G Lingman; K Marsál; S Kreiner
Journal:  Ultrasound Obstet Gynecol       Date:  2001-06       Impact factor: 7.299

Review 7.  Evaluation of the fetal coronary circulation.

Authors:  A A Baschat; U Gembruch
Journal:  Ultrasound Obstet Gynecol       Date:  2002-10       Impact factor: 7.299

Review 8.  How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.

Authors:  Zarko Alfirevic; Devender Roberts; Vanessa Martlew
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-02-10       Impact factor: 2.435

Review 9.  Thrombosis in pregnancy: maternal and fetal issues.

Authors:  I A Greer
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

10.  Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus.

Authors:  E Ferrazzi; M Bozzo; S Rigano; M Bellotti; A Morabito; G Pardi; F C Battaglia; H L Galan
Journal:  Ultrasound Obstet Gynecol       Date:  2002-02       Impact factor: 7.299

View more
  39 in total

Review 1.  Fetal and umbilical Doppler ultrasound in normal pregnancy.

Authors:  Zarko Alfirevic; Tamara Stampalija; Nancy Medley
Journal:  Cochrane Database Syst Rev       Date:  2015-04-15

Review 2.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2017-06-13

Review 3.  Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.

Authors:  Sarah J Stock; Leanne Bricker; Jane E Norman; Helen M West
Journal:  Cochrane Database Syst Rev       Date:  2016-07-12

4.  Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by aryl hydrocarbon receptor nuclear translocator (ARNT).

Authors:  Emily J Su; Hong Xin; Ping Yin; Matthew Dyson; John Coon; Kathryn N Farrow; Karen K Mestan; Linda M Ernst
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

Review 5.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.

Authors:  Emily J Su
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 6.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

7.  Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies.

Authors:  Suneet P Chauhan; Madeline Murguia Rice; William A Grobman; Jennifer Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Kenneth J Leveno; Steve N Caritis; Mona Prasad; Alan T N Tita; George Saade; Yoram Sorokin; Dwight J Rouse; Jorge E Tolosa
Journal:  Obstet Gynecol       Date:  2017-09       Impact factor: 7.661

8.  Routine antenatal ultrasound in low- and middle-income countries: first look - a cluster randomised trial.

Authors:  R L Goldenberg; R O Nathan; D Swanson; S Saleem; W Mirza; F Esamai; D Muyodi; A L Garces; L Figueroa; E Chomba; M Chiwala; M Mwenechanya; A Tshefu; A Lokangako; V L Bolamba; J L Moore; H Franklin; J Swanson; E A Liechty; C L Bose; N F Krebs; K Michael Hambidge; W A Carlo; N Kanaiza; F Naqvi; I S Pineda; W López-Gomez; D Hamsumonde; M S Harrison; M Koso-Thomas; M Miodovnik; D D Wallace; E M McClure
Journal:  BJOG       Date:  2018-06-15       Impact factor: 6.531

Review 9.  Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.

Authors:  Diana M Bond; Adrienne Gordon; Jon Hyett; Bradley de Vries; Angela E Carberry; Jonathan Morris
Journal:  Cochrane Database Syst Rev       Date:  2015-11-24

Review 10.  Use of biochemical tests of placental function for improving pregnancy outcome.

Authors:  Alexander E P Heazell; Melissa Whitworth; Lelia Duley; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.